Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others

Jul 29, 2015, 12:10 ET from Research and Markets

DUBLIN, July 29, 2015 /PRNewswire/ --

Research and Markets ( has announced the addition of the "Global Biosimilars Market, 2015 - 2025" report to their offering.

The Global Biosimilars Market, 2015 - 2025' report provides an extensive study of the rapidly growing biosimilars market. With the blockbuster biologics losing patent protection and biotechnology industry striving to minimize costs, biosimilars are being viewed as viable substitutes to the highly expensive biological medications. The study presents an in-depth review of the developments in established markets and emerging regions, with respect to the market landscape, global and local players, regulatory scenario and emerging opportunities. It provides a detailed analysis of the worldwide pipeline of biosimilars on key parameters such as product categories, indications, biosimilar targets and status of development.

The study presents a comprehensive view of key product classes into which biosimilars can be categorized; these include monoclonal antibodies (mAbs), insulin, interferons, G-CSF/ GM-CSF, erythropoietins and others. We have highlighted some of the important aspects specific to these product categories including regulatory guidelines, development challenges, marketed / pipeline biosimilars, sales data (where available) and information on patent expiry of the reference products.

The report assesses some of the key drivers that have governed the evolution of biosimilars market over the past several years along with an elaborate discussion on the future trends that will shape the market in the coming years. One of the focus areas of this study is to estimate size of the future opportunity in the biosimilars market over the next decade, segmented on the basis of geographical clusters and product categories.

The study also provides information on some of the most recent activities in this market; amongst others, these include growing collaborations, investment activity and technological advancements. In addition to some of the well-known benefits and a promising outlook, the study also highlights considerable challenges currently prevalent in the market. Examples of such challenges include manufacturing complexities, heterogeneous regulatory framework, and associated safety and efficacy issues. Nevertheless, these challenges are paving the way for new strategies and technological improvements, which will indeed be advantageous in the long run.

The report provides market forecasts for the time period 2020 and 2025. The research, analysis and insights presented in this report is backed by a deep understanding of key insights gathered both from secondary and primary research.

Key Topics Covered:

1. Preface

2. Executive Summary

3. Introduction

4. Biosimilars: Developed Markets

5. Biosimilars: Emerging Markets

6. Global Market Overview

7. Market Dynamics

8. Monoclonal Antibody Biosimilars

9. Insulin Biosimilars

10. Biosimilar Interferons

11. Other Leading Biosimilar Markets

12. Recent Developments

13. Outsourcing of Biosimilars

14. Market Forecast

15. Conclusion

16. Interview Transcripts

17. Appendix 1: Tabulated Data

18. Appendix 2: List of Companies and Organisations

Companies Mentioned - 35 of the 300+ Companies Featured

- 3S Bio Inc.
- Abbott
- AbZ Pharma
- Accord Healthcare Ltd.
- Actavis
- Aequus BioPharma
- AET Biotech
- Agila Biotech
- Alvartis Pharma
- Alvogen
- Amega Biotech
- Amgen
- Anhui Anke Biotechnology (Group) Co., Ltd
- Anika Therapeutics
- ANMAT (Argentina)
- Apotex
- Aprogen Inc.
- AryoGen
- ASKA Pharmaceutical Co. Ltd.
- Aspen Pharmacare Australia
- Avesthagen
- Axicorp GmbH
- Barr Pharmaceuticals
- Baxter International
- Bayer Healthcare
- Beacon Pharmaceuticals Ltd.
- Beijing Four Rings Bio-Pharmaceutical
- Beijing ShuangLu Pharmaceutical Co., Ltd.
- Bharat Serums
- Binex
- Bio Process
- Bio Profarma SA
- Bio Sidus SA
- Biocad

For more information visit

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact: Laura Wood , +353-1-481-1716,

SOURCE Research and Markets